Upton, NY, United States of America

Zizhong Li

This inventor holds 1 USPTO granted patent. Top assignee: Brookhaven Science Associates, Lcc. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zizhong Li. Retrieved from https://idiyas.com/inventor/zizhong-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zizhong Li: Innovator in Pharmaceutical Chemistry

Introduction

Zizhong Li is a notable inventor based in Upton, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel methods for manufacturing important chemical compounds.

Latest Patents

Zizhong Li holds 1 patent for a process titled "Process for the manufacture of 117Sn diethylenetriaminepentaacetic acids." This innovative method allows for the use of DTPA, a toxic chelating agent, in an approximately 1:1 ratio to Sn(Sn) under various conditions, including aqueous environments and organic solvents like methylene chloride. The patent also includes a pharmaceutical composition produced by this method, which is aimed at treating bone tumors and alleviating pain associated with bone cancer.

Career Highlights

Zizhong Li is affiliated with Brookhaven Science Associates, LLC, where he continues to advance research in pharmaceutical applications. His work has implications for improving treatment options for patients suffering from serious health conditions.

Collaborations

Zizhong has collaborated with esteemed colleagues such as Suresh C. Srivastava and George E. Meinken, contributing to a rich environment of innovation and research.

Conclusion

Zizhong Li's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in addressing complex medical challenges. His work continues to pave the way for advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…